Summary
The AI response correctly states that Amitiza is lubiprostone. However, it overstates adverse-effect support by listing Headache and Abdominal pain as common side effects, which the provided label excerpt does not support; Nausea and Diarrhea are listed but labeled as partially supported; additional adverse reactions (Syncope/Hypotension, Dyspnea) present in the label are not addressed.
Category Scores
Accurate Statements
Amitiza is lubiprostone.
11 DESCRIPTION
Nausea is a common side effect of Amitiza.
6 ADVERSE REACTIONS (partially supported)
Diarrhea is a common side effect of Amitiza.
6 ADVERSE REACTIONS (partially supported)
Unsupported Statements
Headache is a common side effect of Amitiza.
Absent from the label's listed adverse reactions in 6 ADVERSE REACTIONS.
Abdominal pain is a common side effect of Amitiza.
Absent from the label's listed adverse reactions in 6 ADVERSE REACTIONS.
Contradictions
Low
AI Statement
Headache is a common side effect of Amitiza.
Label Reference
6 ADVERSE REACTIONS
Low
AI Statement
Abdominal pain is a common side effect of Amitiza.
Label Reference
6 ADVERSE REACTIONS
Important Omissions
Other labeled adverse reactions not explicitly claimed (e.g., Syncope and Hypotension; Dyspnea) are omitted from the claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Claims include some adverse effects but misclassify others; overall safety implications depend on comprehensive label context.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Misalignment on adverse reactions: Headache and Abdominal pain are not supported as common adverse effects by the provided label excerpt.
Suggested Improvement
Align adverse reaction claims with the label: include only nausea and diarrhea as supported adverse effects; optionally acknowledge other ARs listed in the label (syncope, hypotension, dyspnea) if addressed; remove unsupported statements.